|
|
|
|
IRVINE--- ISTA Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2008 |
| 8/29/2008 @ 8:34 AM
print this article -
email to a friend -
join our eNewsletter
|
 |
ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA), today announced it will present at the Thomas Weisel Partners Healthcare Conference at 11:30 a.m. Eastern Time on Thursday, September 4, 2008 at the Four Seasons Hotel in Boston, MA.
ISTA's President and Chief Executive Officer, Vicente Anido, Jr., Ph.D., will provide an update on the Company's commercial and clinical progress. To access the live audio broadcast or the subsequent archived recording log onto www.istavision.com/. Please connect to the website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.
About ISTA
ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at www.istavision.com/. |
| Orange County |
|
|
| |
| Thursday, December 4, 2008 |
 |
|
IRVINE--- ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom 0.09% Posted 3:25 PM PST
MISSION VIEJO--- Steve Geringer Appointed to Aperture Health Board of Directors Posted 9:53 AM PST
NEWPORT BEACH--- White Paper is First of Many TriZetto Resources to Help Payer Organizations Adopt ICD-10 Diagnostic Coding System Posted 7:44 AM PST
IRVINE--- Epicor Cited as an Order Management Solutions Leader by Independent Research Firm Posted 7:43 AM PST
|
| |
| Wednesday, December 3, 2008 |
|
|
IRVINE--- Solarflare Now Shipping Sub 4 Watt, Production-Ready 65nm Triple-Speed 10GBASE-T Silicon Posted 7:27 AM PST
|
| |
| Tuesday, December 2, 2008 |
|
|
ALISO VIEJO--- Networks In Motion Integrates INRIX Total Fusion Traffic into Mobile Navigation Applications Posted 4:14 PM PST
IRVINE--- Mitsubishi Digital Electronics America Announces MH2850U Projector with DICOM Simulation Mode for Medical Training Posted 3:59 PM PST
ALISO VIEJO--- Clarient Introduces Second Gene Mutation Test for Colorectal Cancer Posted 9:00 AM PST
COSTA MESA--- Oxygen Biotherapeutics, Inc. Provides Update on Product Development Plans Posted 8:58 AM PST
LAGUNA NIGUEL--- Aeolus Pharmaceuticals Completes Fifth Closing of Senior Convertible Debt Financing Posted 8:57 AM PST
IRVINE--- Freedom Interactive Launches New Real Estate Vertical Across More than 40 Web Sites Posted 8:56 AM PST
IRVINE--- Visiogen Appoints Seasoned Executive as Chief Financial Officer Posted 8:55 AM PST
IRVINE--- BIOLASE Cuts Back Its Work Force by 20% Posted 8:30 AM PST
IRVINE--- Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors Posted 8:27 AM PST
SAN JUAN CAPISTRANO--- 3DiJoy Launches PC-based Motion-Sensitive Video Gaming Solution in North America Posted 8:26 AM PST
|
| |
| Monday, December 1, 2008 |
|
|
LAGUNA NIGUEL--- Symwave’s Momentum Growing with Key Executive Hires to Lead Company’s Move into High Profile USB 3.0 Market Posted 4:28 PM PST
TUSTIN--- Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies Posted 8:50 AM PST
IRVINE--- Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug Posted 8:44 AM PST
IRVINE--- Westinghouse Licenses AdtekMedia's PumpTop TV Design Posted 8:40 AM PST
IRVINE--- SMC Networks Samples First 320 Mbps Downstream DOSCIS 3.0-based Cable Modem for the Enterprise Posted 8:37 AM PST
IRVINE--- ATEN Technology Launches Combo KVM Switches With PS/2-USB Connectivity Support Posted 8:34 AM PST
IRVINE--- Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of April 2, 2009 American Society of Hematology conference Posted 8:25 AM PST
IRVINE--- Spectrum Pharmaceuticals to Host Conference Call Detailing ZEVALIN Joint Venture and Near-Term Strategy Posted 8:24 AM PST
|
| |
| Monday, November 24, 2008 |
|
|
TUSTIN--- Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections Posted 4:29 PM PST
COSTA MESA--- Irvine Sensors Included in Pilot Program by U.S. Army Posted 4:26 PM PST
ALISO VIEJO--- Valeant Reports Encouraging End of Treatment Results with Taribavirin at Treatment Week 48 in Phase Iib Study Posted 7:48 AM PST
COSTA MESA--- Oxygen Biotherapeutics, Inc. Creates Web-based Shareholder Forum For Interactive Communications With Investors Posted 7:46 AM PST
ALISO VIEJO--- California-Based UST Global is One of 21 Companies Positioned in the 2008 North American Offshore Applications Services Magic Quadrant Posted 7:45 AM PST
|
|
|
|
|
|
FreshNews.com Jobs Change DAILY
We Have 5,000 + Job Listings! Open Your FREE Account
Employers or Job Searchers Get Started Now! Click Here
|
